The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boulven, I.
Right arrow Articles by Naccache, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boulven, I.
Right arrow Articles by Naccache, P. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
The Journal of Immunology, 2006, 176: 7621-7627.
Copyright © 2006 by The American Association of Immunologists

Class IA Phosphatidylinositide 3-Kinases, rather than p110{gamma}, Regulate Formyl-Methionyl-Leucyl-Phenylalanine-Stimulated Chemotaxis and Superoxide Production in Differentiated Neutrophil-Like PLB-985 Cells1

Isaline Boulven, Sylvain Levasseur, Sébastien Marois, Guillaume Paré, Emmanuelle Rollet-Labelle and Paul H. Naccache2

Centre de Recherche en Rhumatologie et Immunologie, Centre de Recherche du Centre Hospitalier de l’Université Laval and Department of Medicine, Faculty of Medicine, Laval University, Sainte-Foy, Québec, Canada


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
Class I PI3Ks, through the formation of phosphatidylinositol-3,4,5-trisphosphate (PI(3,4,5)P3), are thought of as essential elements of the neutrophil response to chemotactic factors. Moreover, the recent development of PI3K-deficient mice and isoform-specific inhibitors enabled examinations of the contribution of the distinct PI3K isoforms in neutrophil activation. However, the results of these various studies are conflicting, and the exact role of the different PI3K isoforms is not yet clearly established, particularly in human cells. In the present study, we used a different approach to assess the role of the distinct PI3K isoforms in response to the chemotactic agent fMLP. We inhibited PI3K activities by the transient expression following nucleofection of dominant negative mutants of either p85{alpha} or p110{gamma} in the human myeloid cell line PLB-985, which can be induced to express a neutrophil-like phenotype. The data obtained with this approach showed that the production of PI(3,4,5)P3 triggered by fMLP is biphasic, with a peak of production observed in a short time period that entirely depends on p110{gamma} activity, and a delayed phase that is mediated by class IA PI3K. We also provide evidence that the PI3K-dependent functional responses (i.e., superoxide production and chemotaxis) induced by the chemotactic factor mainly involve PI3K IA and, by implication, the delayed phase of PI(3,4,5)P3 production, whereas p110{gamma} and the early peak of PI(3,4,5)P3 do not play major roles in the initiation or the control of these responses.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 Disclosures
 References
 
The activation of human polymorphonuclear neutrophils (PMNs)3 by chemotactic factors leads to the stimulation of multiple signal transduction pathways and is associated with the production of a variety of second messengers, among which are polyphosphoinositides. Of the enzymes involved in generating distinct phosphoinositides, members of a family of lipid kinases known as PI3Ks are thought to play critical although incompletely characterized roles in the initiation and control of various neutrophil functions, including chemotaxis, adhesion, phagocytosis, respiratory burst, and apoptosis (1, 2, 3, 4).

The PI3K family is a group of intracellular proteins that catalyze the phosphorylation of the D3 position of phosphoinositides. Based on their substrate specificity, three classes of PI3Ks can be defined. Of particular interest to neutrophil physiology are class I PI3Ks, which are further divided into class IA and class IB. Class IA enzymes comprise three types of p110 catalytic subunits (p110{alpha}, p110beta, and p110{delta}), which are activated primarily by tyrosine kinases and are associated predominantly with a p85{alpha} regulatory subunit (5, 6). In contrast to class IA PI3Ks, one member of the class IB PI3K family, p110{gamma}, acts downstream of G protein-coupled receptors. It does not associate with p85 family proteins but interacts rather with p101 (7) and/or p84 (8) regulatory proteins. All of the class I PI3Ks phosphorylate phosphatidylinositol, phosphatidylinositol 4-phosphate, and phosphatidylinositol 4,5-bisphosphate in vitro, but phosphatidylinositol 4,5-bisphosphate is the predominant substrate in cells, and the major product of these kinases is phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3). The latter is a key lipid second messenger that controls a wide range of cellular responses via downstream effectors that include, among others, adaptor proteins, protein kinases, nucleotide exchange factors, and GTPase-activating proteins (5, 6, 9).

Using PI3K inhibitors (wortmannin and LY294002), a number of effects of neutrophil activation have been shown to be PI3K dependent (10, 11, 12, 13). However, the specific roles of the class I PI3K isoforms in neutrophil responses have long been difficult to evaluate because of the absence (until very recently) of PI3K inhibitors specific for individual family members. The development of PI3K-deficient mice enabled key roles for specific PI3K isoforms to be uncovered, although certain results are conflicting. A critical role of p110{gamma} in neutrophil functions was suggested by different studies conducted in p110{gamma}-null mice. Indeed, analysis performed with p110{gamma} knockout mice showed decreased migration (14, 15, 16, 17, 18) and reduced respiratory burst (16, 17, 18) in neutrophils stimulated by chemotactic agents. These studies reached the conclusion that p110{gamma} was the sole PI3K isoform coupled to the activation of neutrophil by chemoattractants. However, others have shown that tyrosine phosphorylation events and, by implication, class IA PI3Ks are involved in PI(3,4,5)P3 formation induced by chemotactic factors (11, 19, 20). Moreover, a recent study based on the use of a specific inhibitor of p110{delta} indicated that this isoform was implicated in neutrophil migration (21). A possible role of p110{delta} in PI(3,4,5)P3 formation and in the chemotactic behavior of neutrophils stimulated by G protein-coupled receptor was also shown by using p110{delta}-null mice (22).

In the present study, we aimed to further characterize the role of the different isoforms of PI3Ks in PI(3,4,5)P3 formation and in neutrophil responses to the chemotactic factor fMLP. We examined the roles of PI3K IA and IB using differentiated neutrophil-like PLB-985 cells (dPLB-985) in which PI3K activity was inhibited by the transient expression of dominant negative mutants of either p85{alpha} or p110{gamma}. Our data confirmed that p110{gamma} represents the major PI3K isoform activated in response to fMLP in short time periods. However, our results also indicated that class IA PI3Ks are implicated in the formation of PI(3,4,5)P3 at longer times of fMLP stimulation and play a major role in the responses triggered by the chemotactic factor.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 Disclosures
 References
 
Reagents and antibodies

Wortmannin, sodium orthovanadate, DMSO, and fMLP were purchased from Sigma-Aldrich. Aprotinin and leupeptin were bought from Roche Diagnostic Systems. [32P]Orthophosphate (1000 Ci/mmol) and the ECL reagents used for immunoblotting were obtained from PerkinElmer. Calcein-acetoxymethyl ester was obtained from Molecular Probes. Cytochrome c was purchased from MP Biomedicals. RPMI 1640 was obtained from Invitrogen Life technologies. Penicillin/streptomycin and FBS were purchased from Wisent. Anti-p110{gamma} antisera were raised in rabbits as described previously (23). Anti-p85{alpha} was obtained from Upstate Biotechnology (catalog number 06-195). HRP-labeled donkey anti-rabbit IgG was purchased from Jackson ImmunoResearch Laboratories (catalog number 711-035-152).

Vectors

The pcDNA3.1 vector was obtained from Invitrogen Life Technologies. The cDNA coding for kinase-dead (KD) mutant (K832R) p110{gamma} (designated as p110{gamma} KD) (24) was provided by Dr. M. P. Wymann (University of Basel, Basel, Switzerland) and subcloned in the pcDNA3.1 vector. The cDNA coding for deleted mutant p85{alpha} (designated as p85{Delta}) (25) was provided by Dr. B. Barbeau (Centre de Recherche en Infectiologie, Université Laval, Sainte-Foy, Quebec, Canada) and subcloned in the pcDNA3.1 vector. The pEGFP-C1 vector was purchased from Clontech Laboratories.

Cells

PLB-985 cells (from the German Collection of Microorganisms and Cell Cultures (DSMZ)) were grown in RPMI 1640 medium containing 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C in a humidified atmosphere of 5% CO2. The cells were maintained in culture for 12 passages before new batches were thawed. To induce a differentiation to a neutrophil-like phenotype, PLB-985 cells were cultured in medium supplemented with 1.25% DMSO for 5 days before each experiment.

Peripheral blood PMNs were obtained from healthy adult volunteers and sterilely isolated as described previously (26).

Transfection

Differentiated PLB-985 cells were transiently transfected using the Nucleofector system from Amaxa Biosystems. After centrifugation, 10 x 106 cells were suspended in 100 µl of prewarmed Nucleofector solution (Lymphocyte B kit) containing 8 µg of vector pEGFP-C1 (encoding for the enhanced GFP), pcDNA3.1, p110{gamma} KD, or p85{Delta}. The samples were transferred into an electroporation cuvette, and transfections were performed with the electrical setting U-15. After nucleofection, the cells were immediately transferred into prewarmed complete RPMI 1640 medium containing 1.25% DMSO and cultured at 37°C in a humidified atmosphere of 5% CO2. At specific times after nucleofection, cells were harvested and resuspended in Mg2+-free HBSS containing 1.6 mM CaCl2 for analysis. Similar transfection efficiencies and functional preservation were obtained using the kits for lymphocyte B, lymphocyte T, dendritic cells, and PLB-985 cells (data not shown).

Immunoblotting of PI3Ks

Transfected PLB-985 cell suspensions (20 x 106 cells/ml) were added to an equal volume of boiling 2x Laemmli’s sample buffer (composition of 1x 62.5 mM Tris-HCl (pH 6.8), 4% (w/v) SDS, 5% (v/v) 2-ME, 8.5% (v/v) glycerol, 2.5 mM orthovanadate, 10 mM para-nitrophenylphosphate, 10 µg/ml leupeptin, 10 µg/ml aprotinin, and 0.025% bromophenol blue) and boiled for 10 min. Samples were then subjected to electrophoresis on 7.5–20% SDS-polyacrylamide gels and transferred to Immobilon polyvinylidene difluoride membranes (Millipore). Immunoblotting was performed as follows. Nonspecific sites were blocked using 2% gelatin in TBS-Tween 20 (25 mM Tris-HCl (pH 7.8), 190 mM NaCl, and 0.15% Tween 20) for 20 min at 37°C. Anti-p110{gamma} (final dilution of 1/1000) or anti-p85 (final dilution of 1/3000) Abs were incubated with the membranes for 1 h at 37°C in TBS-Tween 20. The membranes were then washed three times at room temperature in TBS-Tween 20 for a total duration of 30 min and incubated with HRP-labeled donkey anti-rabbit IgG for 30 min at 37°C at a final dilution of 1/20,000 in TBS-Tween 20. The membranes were washed three times with TBS-Tween 20 at room temperature, and the protein bands were revealed using the ECL Western blotting detection system following the manufacturer’s directions.

PI(3,4,5)P3 formation

Cells (50 x 106 cells/ml) were incubated with 0.5 mCi/ml [32P]orthophosphate at 37°C in a labeling buffer (110 mM NaCl, 10 mM KCl, 1 mM MgCl2, 10 mM glucose, 1.6 mM CaCl2, and 30 mM HEPES (pH 7,4)) for 90 min for differentiated PLB-985 cells and 60 min for PMNs. Unincorporated radioactivity was discarded, and the cells were washed twice in HBSS. The cells were resuspended at 10 x 106 cells/ml in HBSS for differentiated PLB-985 cells and 50 x 106 cells/ml for PMNs and then stimulated with fMLP (10–7 M) for the indicated time. The reactions were stopped by the transfer of 100 µl of the cells into 400 µl of CHCl3-MeOH-HCl (1:1:0.1; v/v/v), followed by rapid vortexing (15–30 s). The samples were centrifuged for 5 min at 13,000 x g, and the organic phase (lower phase) was transferred into borosilicate tubes. The samples were applied to oxalate-treated silica gel 60 plates (EMD Chemicals), which were developed in chloroform-acetone-methanol-acetic acid-H2O (80:30:26:24:14; v/v/v/v/v) for 3h. The plates were dried, and the products were visualized with a bioimaging analyzer (Fuji Film BAS-1800).

Measurement of PLB-985 chemotactic responses

Differentiated PLB-985 cells, transfected with pcDNA3.1, p110{gamma} KD, or p85{Delta}, were resuspended in HBSS containing 10% FBS (HBSS/FBS) at 107 cells/ml. The cells were preincubated with 5 µg/ml calcein-acetoxymethyl ester at 37°C for 30 min in the dark with constant agitation. The cells were then washed and resuspended in HBSS/FBS at 2 x 106 cells/ml. For assays in the presence of wortmannin, untransfected dPLB-985 cells were incubated with 5 µg/ml calcein-acetoxymethyl ester and then washed and incubated at 37°C for 10 min with either wortmannin (200 nM in 0.01% DMSO final concentration) or DMSO (0.01%). Cell migration was monitored using a 96-well ChemoTX disposable chemotaxis system (Neuro Probe). The wells of the lower chamber of the plate were filled with 31 µl of fMLP at the indicated concentrations. The polycarbonate filters (3 µM) were positioned on the plate, and transfected dPLB-985 cells (30 µl; 60,000 cells/well) were placed on the filter and allowed to migrate for 120 min at 37°C in the presence of 5% CO2 in the dark. The cells that had not migrated were removed by gently wiping the filters with a tissue. The fluorescence of the cells in the filters was measured with a microplate fluorescence reader (FL600 from Bio-Tek Instruments; excitation and emission wavelengths were 485 and 530 nm, respectively). The fluorescence from known numbers of differentiated PLB-985 was obtained by placing them into the bottom chamber. The results are expressed as the percentage of the maximal response.

Superoxide measurements

Superoxide production was measured using the reduction of cytochrome c assay. Differentiated PLB-985 cells transfected with pcDNA3.1, p85{Delta}, or p110{gamma} KD (2 x 107 cells/ml) were preincubated for 10 min at 37°C in the presence of 125 µM cytochrome c. Cells were then stimulated at room temperature by adding fMLP (10–7 M), and the differences between the OD readings at 550 nm and 540 nm were monitored for 5 min. For assays in the presence of wortmannin, untransfected dPLB-985 cells were preincubated for 10 min at 37°C with wortmannin (200 nM in 0.01% DMSO final concentration) or DMSO (0.01%) in the presence of 125 µM cytochrome c before being stimulated. The results are expressed as the percentage of the maximal response.

Statistical analysis

The data were analyzed using the Student paired t test (two-tailed). The levels of significance (*, p < 0.05; **, p < 0.01; Figs. 4 and 8) were determined between the cells transfected with p110{gamma}KD or p85{Delta}, and the cells were transfected with the empty vector pcDNA3.1.


Figure 4
View larger version (12K):
[in this window]
[in a new window]
  		FIGURE 4. Effect of p110{gamma} KD and p85{Delta} transfection on the peak of PI(3,4,5)P3 production induced by fMLP. dPLB-985 cells were nucleofected with pcDNA3.1, p110{gamma} KD, or p85{Delta} as described in Materials and Methods. Four hours after transfection, cells were removed and labeled for 90 min with [32P]orthophosphate. The cells were then stimulated with fMLP (10–7 M) for 30 s. The amounts of PI(3,4,5)P3 was measured as described in Materials and Methods. The values are expressed as the percentage of the unstimulated cells and represent the means of at least five separate experiments. **, p < 0.01.

 

Figure 8
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 8. Effect of p85{Delta} transfection on chemotaxis and superoxide production stimulated by fMLP. dPLB-985 cells were nucleofected with either empty pcDNA3.1 or p85{Delta} as described in Materials and Methods. A, Four hours after transfection, cells were removed and stimulated by fMLP (10–7 M). Superoxide production was monitored as described in Materials and Methods. The results, expressed as the percentage of the maximal response, represent the chemotaxis assays that were performed as described in Materials and Methods. The results, expressed as the percentage of the maximal response, represent the means of four separate experiments, each done in duplicate. The maximal superoxide response was 1.57 ± 0.20 nmol of O2– per 106 cells in 5 min. The maximal number of cells migrating in response to fMLP was 4247 ± 375 cells. **, p < 0.01.

 

   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 Disclosures
 References
 
Production of PI(3,4,5)P3 in differentiated neutrophil-like PLB-985 stimulated by fMLP

In this study we used a human neutrophil-like cellular model, the human myeloid cell line PLB-985, to examine the role of class IA and class IB PI3Ks in the responses to the chemoattractant fMLP. These cells can be differentiated with DMSO to express a neutrophil-like phenotype (27).

The experiments whose results are summarized in Fig. 1A showed that the stimulation of dPLB-985 cells by fMLP resulted in rapid increases of the levels of PI(3,4,5)P3. These effects were time dependent and peaked within 30 to 60 s of the addition of the chemoattractant. PI(3,4,5)P3 formation then gradually declined, with a sustained phase that persisted for at least 10 min. The kinetics of PI(3,4,5)P3 accumulation in fMLP-stimulated PMNs were similar (Fig. 1B) to those observed in dPLB-985, indicating that the latter cells represent a useful model system in which to study the activation of PI3Ks in response to this chemotactic factor.


Figure 1
View larger version (17K):
[in this window]
[in a new window]
  		FIGURE 1. Accumulation of PI(3,4,5)P3 in response to fMLP in dPLB-985 and PMNs. 32P-labeled dPLB-985 (A) and PMNs (B) were stimulated with fMLP (10–7 M) for the indicated times. PI(3,4,5)P3 formation was visualized as described in Materials and Methods. The results of the densitometric analysis are expressed as the percentage of the unstimulated cells. The values represent the means of at least five separate experiments.

 
Transfection of dPLB-985 cells by nucleofection

To overcome the low transfection efficiency of dPLB-985 cells previously reported (28), we used the Nucleofector (Amaxa Biosystems) technology that is a novel gene transfer method designated for hard-to-transfect cell lines. To examine the efficiency of this technique, we first nucleofected the pEGFP-C1 vector encoding for enhanced GFP into dPLB-985 as described in Materials and Methods. Differentiated PLB-985 cells transfected with pEGFP-C1 were analyzed by flow cytometry at different time points after nucleofection. As depicted in Fig. 2, enhanced GFP (EGFP) expression was detectable within 2 h postnucleofection. Transfection efficiencies of >60% were reached as early as 4 h postnucleofection, and EGFP expression continued to increase slowly up to 24 h. The proportion of dead cells was determined by parallel trypan blue staining. The proportion of trypan blue-positive cells increased progressively to 65% by 24 h postnucleofection. In contrast, >60% of the cells excluded trypan blue at a time when EGFP expression was near maximal (4 h), indicating that this novel technology represents a feasible approach to introduce plasmids in differentiated neutrophil-like PLB-985 cells and to specifically target intracellular proteins. Based on these data, all of the subsequent analyses were performed 4 h after nucleofection.


Figure 2
View larger version (15K):
[in this window]
[in a new window]
  		FIGURE 2. Time course of EGFP expression after nucleofection of dPLB-985. dPLB-985 were nucleofected with pEGFP-C1 and incubated as described in Materials and Methods. Cells were removed at the indicated times posttreatment, and EGFP expression was determined by FACS analysis. The proportion of dead cells was determined by trypan blue staining. The results shown represent the means of three separate experiments.

 
Effect of p110{gamma} KD and p85{Delta} transfection on the accumulation of PI(3,4,5)P3 induced by fMLP

In an effort to identify the PI3K isoform activated by fMLP, we transiently transfected differentiated neutrophil-like PLB-985 cells with an empty vector (pcDNA3.1) or dominant negative mutants of PI3K{gamma} (p110{gamma} KD) or p85{alpha} (p85{Delta}). Transfected dPLB-985 cells were analyzed by immunoblots using Abs against either p110{gamma} or p85{alpha}. The results of these experiments are depicted in Fig. 3, which shows the presence of bands corresponding to p110{gamma} KD (Fig. 3A) and p85{Delta} (Fig. 3B) in the appropriate cells, indicating that both mutant proteins were properly expressed 4 h after nucleofection.


Figure 3
View larger version (12K):
[in this window]
[in a new window]
  		FIGURE 3. Transfection of p110{gamma} KD and p85{Delta} in dPLB-985. dPLB-985 cells were nucleofected with empty pcDNA3.1, p110{gamma} KD, or p85{Delta} as described in Materials and Methods. Four hours after transfection, cells were removed and total proteins were analyzed by immunoblotting with anti-p110{gamma} (A) or anti-p85 (B). The data show the results of one determination representative of four separate experiments.

 
We then examined the accumulation of PI(3,4,5)P3 in response to fMLP in control or p110{gamma} KD- and p85{Delta}-transfected cells. As shown in Fig. 4, the peak of PI(3,4,5)P3, observed after 30 s of stimulation with fMLP, was severely inhibited in cells expressing p110{gamma} KD. In contrast, p85{Delta} transfection was without effect on the formation of PI(3,4,5)P3 observed at 30 s poststimulation by fMLP in dPLB-985 cells.

These data indicate that p110{gamma} is the major, if not the only, PI3K isoform responsible of the peak of production of PI(3,4,5)P3 triggered by fMLP in differentiated neutrophil-like PLB-985 at this early time point.

Effect of p110{gamma} KD transfection on the functional responses induced by fMLP

The activation of PI3Ks has been linked to various cell functions in PMNs, including the stimulation of the oxidative burst and cell motility. As shown in Fig. 5, dPLB-985 produced superoxide anions (Fig. 5A) and exhibited a classical bell-shaped chemotactic concentration curve (Fig. 5B) in response to fMLP. Wortmannin, a PI3K inhibitor that affects equally PI3K IA and IB, decreased by >50% the production of superoxide triggered by fMLP in dPLB-985. The chemotactic response of the cells was also dramatically inhibited by wortmannin. These data provide evidence that the functional responsiveness of dPLB-985 cells depends on PI3Ks in much the same way as PMNs.


Figure 5
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 5. Effect of wortmannin on chemotaxis and superoxide production stimulated by fMLP. A, dPLB-985 were incubated for 10 min without or with wortmannin (wort) (200 nM) before stimulation by fMLP (10–7 M). Superoxide production was monitored as described in Materials and Methods. The results, expressed as the percentage of the maximal response, represent the means of three separate experiments. B, dPLB-985 cells were preincubated 10 min without or with wortmannin (wort) (200 nM), and the chemotaxis assays were then performed as described in Materials and Methods. The results are expressed as the percentage of the maximal response and represent the means of three separate experiments, each done in duplicate.

 
We next took advantage of the ability to inhibit the intrinsic activity of p110{gamma} through the transfection of p110{gamma} KD to directly examine the functional involvement of this specific PI3K isoform. In these experiments, dPLB-985 cells were transfected either with empty vector or with p110{gamma} KD, and their ability to produce superoxide anions or to migrate in response to fMLP was monitored. As shown in Fig. 6, neither the production of superoxide nor the chemotactic response induced by fMLP were inhibited in dPLB-985 cells expressing p110{gamma} KD.


Figure 6
View larger version (20K):
[in this window]
[in a new window]
  		FIGURE 6. Effect of p110{gamma} KD transfection on chemotaxis and superoxide production stimulated by fMLP. dPLB-985 cells were nucleofected with either empty pcDNA3.1 or p110{gamma} KD as described in Materials and Methods. A, Four hours after transfection, cells were removed and stimulated by fMLP (10–7 M). Superoxide production was monitored as described in Materials and Methods. The results, expressed as the percentage of the maximal response, represent the means of three separate experiments. B, Four hours after transfection the cells were removed, and the chemotaxis assays were then performed as described in Materials and Methods. The results, expressed as the percentage of the maximal response, represent the means of three separate experiments, each done in duplicate. The maximal superoxide response was 0.81 ± 0.14 nmol of O2– per 106 cells in 5 min. The maximal number of cells migrating in response to fMLP was 3307 ± 256 cells.

 
Effect of p85{Delta} transfection on the delayed formation of PI(3,4,5)P3 and on the functional responses induced by fMLP

The results shown in Fig. 4 and 6 indicate that whereas p110{gamma} is principally responsible for the early peak of PI(3,4,5)P3 accumulation in response to fMLP, it plays little if any role in the initiation and control of the chemotactic and oxidative responses to this chemoattractant. The kinetics of accumulation of PI(3,4,5)P3 shown in Fig. 1 provide evidence for a delayed phase of formation of PI(3,4,5)P3. This finding led us to examine the potential involvement of class IA PI3Ks in these responses.

We first examined the effects of p85{Delta} on the early and late phases of PI(3,4,5)P3 formation. To do so, we obtained complete kinetic curves of the accumulation of PI(3,4,5)P3 in the absence or presence of p110{gamma}KD or p85{Delta}. The results of these experiments are shown in Fig. 7A. It should be noted that the data in this figure derive from two separate series of experiments. Although slight differences in the kinetics can be noted and are probably attributable to experimental variability, both kinetics show an initial peak of PI(3,4,5)P3 accumulation followed by a small but detectable sustained phase. These two phases are most evident at 30–60 s (initial phase) and at 300 s (sustained phase). The data at these two time points are summarized in the histograms shown in Fig. 7B. As shown in Fig. 7A, whereas p85{Delta} had, as previously shown in Fig. 4, no effect on the peak of PI(3,4,5)P3 accumulation observed at 30 s, it dramatically reduced the levels of PI(3,4,5)P3 that were observed in control cells at 5 min. In contrast, the expression of p110{gamma}KD severely reduced the early peak of PI(3,4,5)P3 but had no effect on the accumulation of PI(3,4,5)P3 observed at 5 min poststimulation by fMLP.


Figure 7
View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 7. Effect of p85{Delta} and p110{gamma} KD transfection on the accumulation of PI(3,4,5)P3. dPLB-985 cells were nucleofected with pcDNA3.1 and p85{Delta} or p110{gamma} KD as described in Materials and Methods. Four hours after transfection the cells were removed and labeled for 90 min with [32P]orthophosphate. The cells were then stimulated with fMLP (10–7 M) for the indicated times. The amounts of PI(3,4,5)P3 was measured as described in Materials and Methods. A, Time dependence of the accumulation of PI(3,4,5)P3 in the control and transfected cells. B, Summarization of the results at 30 s and at 5 min. The values are expressed as the percentage of the unstimulated cells and represent the means of at least four separate experiments ± SEM.

 
The effects of the expression of p85{Delta} on the production of superoxide anions and on the chemotactic responses induced by fMLP in dPLB-985 were monitored next. As shown in Fig. 8, the expression of p85{Delta} significantly inhibited the production of superoxide anions and decreased dramatically the chemotactic response induced by fMLP.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
Disclosures
 References
 
Class I PI3Ks and their lipid product PI(3,4,5)P3 are recognized as fundamental elements for the regulation of a vast array of cellular responses, in particular in the immune system (1, 2, 3, 29). However, it is less clear how the multiple isoforms of PI3K fit into this general scheme of PI3K signaling.

In the present study, we aimed to assess the role of the distinct PI3K isoforms in PI(3,4,5)P3 formation and in the neutrophil responses induced by the chemotactic factor fMLP. We thus inhibited PI3K activities by the transient expression of dominant negative mutants of either p85{alpha} or p110{gamma} in the human myeloid cell line PLB-985, which can be induced to express a neutrophil-like phenotype. Nucleofection enabled us to obtain very high levels of transfection while keeping most cells alive. The data obtained with this approach show that the peak of production of PI(3,4,5)P3, triggered at short times by fMLP in differentiated neutrophil-like PLB-985 cells, mainly depends on p110{gamma}. In addition, the lack of effect of p85{Delta} on the initial peak of PI(3,4,5)P3 accumulation provides evidence for the specificity of the effect of the dominant negative p110{gamma}. These results are in agreement with our previous data obtained in PMNs that led us to conclude that p110{gamma} represented the major PI3K activated by fMLP at very early time points (<60 s) following the stimulation of human neutrophils (23). However, in the present study we now provide evidence of the existence of a delayed phase of PI(3,4,5)P3 production that mainly involves class IA PI3K. Thus, the kinetics of fMLP-stimulated PI(3,4,5)P3 accumulation appears to be biphasic, with an early peak that depends on p110{gamma} and a sustained phase that involves class IA PI3Ks.

The idea that both class IA and class IB PI3K isoforms are required in chemoattractant-stimulated PI(3,4,5)P3 formation is supported by earlier studies presenting apparently conflicting results. A major role of p110{gamma} in mediating PI(3,4,5)P3 accumulation was strongly suggested by different studies (16, 17, 18) showing that neutrophils from p110{gamma}–/– mice were unable to produce PI(3,4,5)P3 in response to chemotactic agents. However, there was also evidence for the involvement of class IA PI3Ks. Indeed, the activation of class IA PI3K downstream of chemotactic agent stimulation has been reported, and tyrosine kinase inhibitors have been shown to block chemoattractant-stimulated PI(3,4,5)P3 accumulation in neutrophils (11, 19, 20, 21, 30). Recently, the use of a p110{delta}-selective inhibitor and studies conducted in p110{delta}–/– mice have shown a crucial involvement of this PI3K IA isoform in PI(3,4,5)P3 accumulation triggered by fMLP (21, 22). These various results, which were apparently contradictory, suggest that both class IA and class IB PI3Ks are activated following fMLP stimulation. Moreover, a recent study using a series of PI3K isoform-specific inhibitors has provided evidence for a sequential activation of class IB and class IA in response to fMLP in TNF-{alpha}-primed neutrophils (31). Although the latter study did not examine the direct effects of the chemotactic factor, the data provided also support the idea that multiple isoforms of PI3Ks are required for chemoattractant-stimulated PI(3,4,5)P3 production.

The mechanisms by which tyrosine kinase dependent-PI3Ks IA are activated downstream of G protein-coupled receptor stimulation are currently unknown. Direct activation of p110beta by Gbeta{gamma} has been described (32, 33), and this mechanism could account in part for the activation of PI3K IA by fMLP. Different lines of evidence suggest that nonreceptor tyrosine kinases, such as the Src family tyrosine kinases, could be involved in the activation of PI3K by chemotactic factors (20, 31). We also observed that PP2, an inhibitor of the Src family tyrosine kinases, significantly reduced the accumulation of PI(3,4,5)P3 in fMLP-stimulated neutrophils (our unpublished data), suggesting that this family of enzymes is implicated in the regulation of the PI(3,4,5)P3 response to the chemotactic agent. The Tec family of tyrosine kinases, which is also activated downstream of fMLP stimulation in neutrophils (34), could also be involved in PI(3,4,5)P3 regulation, although contradictory results have been published in this respect. Indeed, Condliffe et al. (31) showed that LFM-A13, an inhibitor of the Tec family of tyrosine kinases, had no effect on the accumulation of PI(3,4,5)P3 stimulated by fMLP in TNF-{alpha}-primed neutrophils, whereas Gilbert et al. (26) observed that this compound inhibited the accumulation of PI(3,4,5)P3 triggered by the chemotactic factor in neutrophils. These differences may reflect the effect of the priming regimen used in the study by Condliffe et al. (31) or differential effects on PI3Ks and lipid phosphatases.

An interesting aspect of the stimulation of PI(3,4,5)P3 production by fMLP comes from the previous observation that PI(3,4,5)P3 may stimulate its own accumulation, suggesting the existence of a positive feedback loop (35). It was then considered that PI3K IA, activated downstream of p110{gamma}, could mediate this positive feedback loop (1, 36). This idea is supported by the recent work of Condliffe et al. (31), which shows that class IA-driven PI(3,4,5)P3 accumulation induced by fMLP in TNF-{alpha}-primed neutrophils is significantly dependent on the activity of p110{gamma}. However, this finding is contradictory with our present work, which shows that inhibition of the activity of p110{gamma} through the transfection of p110{gamma} KD is without effect on the PI3K IA-dependent accumulation of PI(3,4,5)P3 triggered by fMLP at 5 min. Although we cannot exclude the possibility that the use in our study of dPLB-985 cells rather than PMNs or the use of primed cells in the study from Condliffe et al. (31) accounts for the difference observed, it is also possible that the residual p110{gamma} activity observed in p110{gamma} KD-transfected cells may be sufficient to enable the activation of PI3K IA in our model. We may also consider that the PI(3,4,5)P3-dependent amplification of the signal observed by Weiner et al. (35, 36) in dPLB-985 does not imply p110{gamma}-dependent activation of PI3K IA, but rather that it is mediated by another pathway, possibly involving Rho GTPases, as has also been suggested (35, 36).

A wide variety of neutrophil functions have been shown to be PI3K dependent, including cell motility, adhesion, phagocytosis, respiratory burst, and apoptosis (1, 2, 3, 4). In the present study, we focused on superoxide anion production and chemotaxis, whose dependence on PI3K activity is well documented (2, 4, 37, 38, 39, 40), although the role of the distinct PI3K isoforms in these responses remain unclear. We took advantage of the ability to selectively inhibit PI3K IA and PI3K IB activity through the transfection of dominant negative mutants of p85{alpha} and p110{gamma}, respectively, to directly examine the functional involvement of these specific PI3K isoforms in fMLP responses. The results obtained clearly indicate that chemotaxis and superoxide production induced by the chemotactic factor are significantly dependent on PI3K IA, whereas inhibition of p110{gamma} does not affect these two responses. These results are in disagreement with those obtained in p110{gamma}–/– mice, which showed that the loss of p110{gamma} activity in mice neutrophils dramatically reduced superoxide production (16, 18) and impaired chemotaxis (15, 16, 17, 18) in response to the chemoattractant. However, others studies support the idea that PI3K IA is required for fMLP responses in neutrophils (21, 22). These apparently contradictory results may be in part explained by the recent work of Condliffe et al. (31), which suggests that the regulation of respiratory burst involves different pathways and different PI3K isoforms in mouse and human neutrophils. It is also possible that the possible scaffolding functions of p110{gamma} (which would be expected to be preserved in kinase-dead transfected cells or mice), as opposed to the absence of p110{gamma} in knockout mice (41), may contribute to some of these differences.

It is interesting to note that, in our study, the production of superoxide is similarly inhibited in cells pretreated with wortmannin and in cells transfected with p85{Delta}, suggesting that the PI3Ks involved in the respiratory burst induced by fMLP all belong to the class IA. In contrast, wortmannin was a more potent inhibitor of fMLP-induced chemotaxis than was p85{Delta} transfection. Given that p110{gamma} KD transfection was without effect on chemotaxis, the more drastic effect of wortmannin may arise from non-PI3K-dependent effects of this compound, possibly on myosin L chain kinase (42), which is important for cell migration (39). All these data indicate that the PI3K-dependent respiratory burst and the cell migration induced by fMLP mainly involve PI3K IA, whereas p110{gamma} does not play a major role. The present results call into question the essential role that has of recent years been ascribed to p110{gamma} in neutrophil activation (36, 40). Additional experiments need to be conducted to define more precisely the involvement of this PI3K isoform in the responses induced by the chemotactic factor and to establish the contribution of the multiple waves of PI(3,4,5)P3 production in neutrophil activation

In conclusion, the results of this study indicate that the accumulation of PI(3,4,5)P3 triggered by fMLP in dPLB-985 is biphasic, with a peak of production observed at short time periods that entirely depends on p110{gamma} activity, and a delayed, less intense phase that is mediated by class IA PI3K. The data presented above also provide evidence that the PI3K-dependent superoxide production and chemotaxis induced by the chemotactic factor mainly involves PI3K IA and, by implication, the delayed phase of PI(3,4,5)P3 production, whereas p110{gamma} does not play a major role. Several important questions remain to be investigated, including the elucidation of the basis for the specificity of the signals produced by these distinct PI3Ks, the definition of the roles of the subcellular localization, and the intensity or duration of the production of PI(3,4,5)P3 in the initiation and regulation of the functional responsiveness of human neutrophils.


   Disclosures
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
References
 
The authors have no financial conflict of interest.


   Footnotes
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by grants from the Canadian Institutes for Health Research and by fellowships from the Association pour la Recherche sur le Cancer of France and the Arthritis Society of Canada (to I.B.). P.H.N. is the recipient of the Canada Research Chair on the Physiopathology of the Neutrophil. Back

2 Address correspondence and reprint requests to Dr. Paul H. Naccache, Centre de Recherche en Rhumatologie et Immunologie du Centre Hospitalier de l’Université Laval, Room T1-49, 2705, Boulevard Laurier, Sainte-Foy, Québec Canada, G1V 4G2. E-mail address: Paul.Naccache{at}crchul.ulaval.ca Back

3 Abbreviations used in this paper: PMN, polymorphonuclear neutrophil; PI(3,4,5)P3, phosphatidylinositol 3,4,5-trisphosphate; dPLB-985, differentiated neutrophil-like PLB-985 cells; EGFP, enhanced GFP; KD, kinase dead. Back

Received for publication October 11, 2005. Accepted for publication March 29, 2006.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 Disclosures
 References
 

  1. Stephens, L., C. Ellson, P. Hawkins. 2002. Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr. Opin. Cell Biol. 14: 203-213. [Medline]
  2. Moraes, T. J., G. P. Downey. 2003. Neutrophil cell signaling in infection: role of phosphatidylinositide 3-kinase. Microbes Infect. 5: 1293-1298. [Medline]
  3. Koyasu, S.. 2003. The role of PI3K in immune cells. Nat. Immunol. 4: 313-319. [Medline]
  4. Procko, E., S. R. McColl. 2005. Leukocytes on the move with phosphoinositide 3-kinase and its downstream effectors. BioEssays 27: 153-163. [Medline]
  5. Wymann, M. P., L. Pirola. 1998. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta. 1436: 127-150. [Medline]
  6. Vanhaesebroeck, B., M. D. Waterfield. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253: 239-254. [Medline]
  7. Stephens, L. R., A. Eguinoa, H. Erdjument-Bromage, M. Lui, F. Cooke, J. Coadwell, A. S. Smrcka, M. Thelen, K. Cadwallader, P. Tempst, P. T. Hawkins. 1997. The G beta {gamma} sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 89: 105-114. [Medline]
  8. Suire, S., J. Coadwell, G. J. Ferguson, K. Davidson, P. Hawkins, L. Stephens. 2005. p84, a new Gbeta{gamma}-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110{gamma}. Curr. Biol. 15: 566-570. [Medline]
  9. Rameh, L. E., L. C. Cantley. 1999. The role of phosphoinositide 3-kinase lipid products in cell function. J. Biol. Chem. 274: 8347-8350. [Free Full Text]
  10. Yasui, K., A. Komiyama. 2001. Roles of phosphatidylinositol 3-kinase and phospholipase D in temporal activation of superoxide production in FMLP-stimulated human neutrophils. Cell Biochem. Funct. 19: 43-50. [Medline]
  11. Coffer, P. J., N. Geijsen, L. M’Rabet, R. C. Schweizer, T. Maikoe, J. A. Raaijmakers, J. W. Lammers, L. Koenderman. 1998. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. Biochem. J. 329: 121-130. [Medline]
  12. Niggli, V., H. Keller. 1997. The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils. Eur. J. Pharmacol. 335: 43-52. [Medline]
  13. Nakamura, M., S. Nakashima, Y. Katagiri, Y. Nozawa. 1997. Effect of wortmannin, and 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one (LY294002) on n-formyl-methionyl-leucyl-phenylalanine-induced phospholipase D activation in differentiated HL60 cells: possible involvement of phosphatidylinositol 3-kinase in phospholipase D activation. Biochem. Pharmacol. 53: 1929-1936. [Medline]
  14. Hannigan, M., L. Zhan, Z. Li, Y. Ai, D. Wu, C. K. Huang. 2002. Neutrophils lacking phosphoinositide 3-kinase {gamma} show loss of directionality during N-formyl-Met-Leu-Phe-induced chemotaxis. Proc. Natl. Acad. Sci. USA 99: 3603-3608. [Abstract/Free Full Text]
  15. Thomas, M. J., A. Smith, D. H. Head, L. Milne, A. Nicholls, W. Pearce, B. Vanhaesebroeck, M. P. Wymann, E. Hirsch, A. Trifilieff, et al 2005. Airway inflammation: chemokine-induced neutrophilia and the class I phosphoinositide 3-kinases. Eur. J. Immunol. 35: 1283-1291. [Medline]
  16. Li, Z., H. Jiang, W. Xie, Z. Zhang, A. V. Smrcka, D. Wu. 2000. Roles of PLC-beta2 and –beta3 and PI3K{gamma} in chemoattractant-mediated signal transduction. Science 287: 1046-1049. [Abstract/Free Full Text]
  17. Hirsch, E., V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda, M. P. Wymann. 2000. Central role for G protein-coupled phosphoinositide 3-kinase {gamma} in inflammation. Science 287: 1049-1053. [Abstract/Free Full Text]
  18. Sasaki, T., J. Irie-Sasaki, R. G. Jones, A. J. Oliveira-dos-Santos, W. L. Stanford, B. Bolon, A. Wakeham, A. Itie, D. Bouchard, I. Kozieradzki, et al 2000. Function of PI3K{gamma} in thymocyte development, T cell activation and neutrophil migration. Science 287: 1040-1046. [Abstract/Free Full Text]
  19. Thelen, M., S. A. Didichenko. 1997. G-protein coupled receptor-mediated activation of PI 3-kinase in neutrophils. Ann. NY Acad. Sci. 832: 368-382. [Medline]
  20. Ptasznik, A., E. R. Prossnitz, D. Yoshikawa, A. Smrcka, A. E. Traynorkaplan, G. M. Bokoch. 1996. A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant-stimulated human neutrophils. J. Biol. Chem. 271: 25204-25207. [Abstract/Free Full Text]
  21. Sadhu, C., K. Dick, W. T. Tino, D. E. Staunton. 2003. Selective role of PI3K {delta} in neutrophil inflammatory responses. Biochem. Biophys. Res. Commun. 308: 764-769. [Medline]
  22. Puri, K. D., T. A. Doggett, J. Douangpanya, Y. Hou, W. T. Tino, T. Wilson, T. Graf, E. Clayton, M. Turner, J. S. Hayflick, T. G. Diacovo. 2004. Mechanisms and implications of phosphoinositide 3-kinase {delta} in promoting neutrophil trafficking into inflamed tissue. Blood 103: 3448-3456. [Abstract/Free Full Text]
  23. Naccache, P. H., S. Levasseur, G. Lachance, S. Chakravarti, S. G. Bourgoin, S. R. McColl. 2000. Stimulation of human neutrophils by chemotactic factors is associated with the activation of phosphatidylinositol 3-kinase {gamma}. J. Biol. Chem. 275: 23636-23641. [Abstract/Free Full Text]
  24. Bondeva, T., L. Pirola, G. BulgarelliLeva, I. Rubio, R. Wetzker, M. P. Wymann. 1998. Bifurcation of lipid and protein kinase signals of PI3K {gamma} to the protein kinases PKB and MAPK. Science 282: 293-296. [Abstract/Free Full Text]
  25. Hara, K., K. Yonezawa, H. Sakaue, A. Ando, K. Kotani, T. Kitamura, Y. Kitamura, H. Ueda, L. Stephens, T. R. Jackson, et al 1994. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc. Natl. Acad. Sci. USA 91: 7415-7419. [Abstract/Free Full Text]
  26. Gilbert, C., S. Levasseur, P. Desaulniers, A. A. Dusseault, N. Thibault, S. G. Bourgoin, P. H. Naccache. 2003. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. II. Effects of LFM-A13, a specific Btk inhibitor. J. Immunol. 170: 5235-5243. [Abstract/Free Full Text]
  27. Tucker, K. A., M. B. Lilly, L. Heck, Jr, T. A. Rado. 1987. Characterization of a new human diploid myeloid leukemia cell line (PLB-985) with granulocytic and monocytic differentiating capacity. Blood 70: 372-378. [Abstract/Free Full Text]
  28. Dana, R. R., C. Eigsti, K. L. Holmes, T. L. Leto. 2000. A regulatory role for ADP-ribosylation factor 6 (ARF6) in activation of the phagocyte NADPH oxidase. J. Biol. Chem. 275: 32566-32571. [Abstract/Free Full Text]
  29. Sasaki, T., A. Suzuki, J. Sasaki, J. M. Penninger. 2002. Phosphoinositide 3-kinases in immunity: lessons from knockout mice. J. Biochem. 131: 495-501. [Abstract/Free Full Text]
  30. Stephens, L., A. Eguinoa, S. Corey, T. Jackson, P. T. Hawkins. 1993. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J. 12: 2265-2273. [Medline]
  31. Condliffe, A. M., K. Davidson, K. E. Anderson, C. D. Ellson, T. Crabbe, K. Okkenhaug, B. Vanhaesebroeck, M. Turner, L. Webb, M. P. Wymann, et al 2005. Sequential activation of Class IB and Class IA PI3Ks is important for the primed respiratory burst of human but not murine neutrophils. Blood 106: 1432-1440. [Abstract/Free Full Text]
  32. Kurosu, H., T. Maehama, T. Okada, T. Yamamoto, S. Hoshino, Y. Fukui, M. Ui, O. Hazeki, T. Katada. 1997. Heterodimeric phosphoinositide 3-kinase consisting of p85 and p110 beta is synergistically activated by the beta {gamma} subunits of G proteins and phosphotyrosyl peptide. J. Biol. Chem. 272: 24252-24256. [Abstract/Free Full Text]
  33. Maier, U., A. Babich, B. Nurnberg. 1999. Roles of non-catalytic subunits in Gbeta{gamma}-induced activation of class I phosphoinositide 3-kinase isoforms beta and {gamma}. J. Biol. Chem. 274: 29311-29317. [Abstract/Free Full Text]
  34. Lachance, G., S. Levasseur, P. H. Naccache. 2002. Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils: implication of phosphatidylinositol 3-kinases. J. Biol. Chem. 277: 21537-21541. [Abstract/Free Full Text]
  35. Weiner, O. D., P. O. Neilsen, G. D. Prestwich, M. W. Kirschner, L. C. Cantley, H. R. Bourne. 2002. A PtdInsP(3)- and Rho GTPase-mediated positive feedback loop regulates neutrophil polarity. Nat. Cell Biol. 4: 509-513. [Medline]
  36. Rickert, P., O. D. Weiner, F. Wang, H. R. Bourne, G. Servant. 2000. Leukocytes navigate by compass: roles of PI3K {gamma} and its lipid products. Trends Cell Biol. 10: 466-473. [Medline]
  37. Wu, D. Q., C. K. Huang, H. P. Jiang. 2000. Roles of phospholipid signaling in chemoattractant-induced responses. J. Cell Sci. 113: 2935-2940. [Abstract]
  38. Niggli, V.. 2003. Signaling to migration in neutrophils: importance of localized pathways. Int. J. Biochem. Cell Biol. 35: 1619-1638. [Medline]
  39. Van Haastert, P. J., P. N. Devreotes. 2004. Chemotaxis: signalling the way forward. Nat. Rev. Mol. Cell Biol. 5: 626-634. [Medline]
  40. Hannigan, M. O., C. K. Huang, D. Q. Wu. 2004. Roles of PI3K in neutrophil function. Curr. Top. Microbiol. Immunol. 282: 165-175. [Medline]
  41. Vanhaesebroeck, B., J. L. Rohn, M. D. Waterfield. 2004. Gene targeting: attention to detail. Cell 118: 274-276. [Medline]
  42. Nakanishi, S., S. Kakita, I. Takahashi, K. Kawahara, E. Tsukuda, T. Sano, K. Yamada, M. Yoshida, H. Kase, Y. Matsuda. 1992. Wortmannin, a microbial product inhibitor of myosin light chain kinase. J. Biol. Chem. 267: 2157-2163. [Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Pharmacol. Rev.Home page
R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan, and P. M. Murphy
International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family
Pharmacol. Rev., June 1, 2009; 61(2): 119 - 161.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. E. Anderson, K. B. Boyle, K. Davidson, T. A. M. Chessa, S. Kulkarni, G. E. Jarvis, A. Sindrilaru, K. Scharffetter-Kochanek, O. Rausch, L. R. Stephens, et al.
CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks
Blood, December 15, 2008; 112(13): 5202 - 5211.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
B. Heit, L. Liu, P. Colarusso, K. D. Puri, and P. Kubes
PI3K accelerates, but is not required for, neutrophil chemotaxis to fMLP
J. Cell Sci., January 15, 2008; 121(2): 205 - 214.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
O. Popa-Nita, E. Rollet-Labelle, N. Thibault, C. Gilbert, S. G. Bourgoin, and P. H. Naccache
Crystal-induced neutrophil activation. IX. Syk-dependent activation of class Ia phosphatidylinositol 3-kinase
J. Leukoc. Biol., September 1, 2007; 82(3): 763 - 773.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
L. Liu, K. D. Puri, J. M. Penninger, and P. Kubes
Leukocyte PI3K{gamma} and PI3K{delta} have temporally distinct roles for leukocyte recruitment in vivo
Blood, August 15, 2007; 110(4): 1191 - 1198.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X.-P. Gao, X. Zhu, J. Fu, Q. Liu, R. S. Frey, and A. B. Malik
Blockade of Class IA Phosphoinositide 3-Kinase in Neutrophils Prevents NADPH Oxidase Activation- and Adhesion-dependent Inflammation
J. Biol. Chem., March 2, 2007; 282(9): 6116 - 6125.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boulven, I.
Right arrow Articles by Naccache, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boulven, I.
Right arrow Articles by Naccache, P. H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS